Anti-Kallikrein 6 antibody [EPR23352-128]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Kallikrein 6 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
PRSS18, PRSS9, KLK6, Kallikrein-6, Neurosin, Protease M, SP59, Serine protease 18, Serine protease 9, Zyme
- WB
Lab
Western blot - Anti-Kallikrein 6 antibody [EPR23352-128] (AB272717)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 19383923, 25990935).
Negative control : MDA-MB-231 (PMID : 19383923), HeLa (PMID : 25990935).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-Kallikrein 6 antibody [EPR23352-128] (ab272717) at 1/1000 dilution
Lane 1:
MDA-MB-468 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 27 kDa
Observed band size: 27 kDa
false
- WB
Lab
Western blot - Anti-Kallikrein 6 antibody [EPR23352-128] (AB272717)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 11018688).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-Kallikrein 6 antibody [EPR23352-128] (ab272717) at 1/1000 dilution
Lane 1:
Human milk at 20 µg
Lane 2:
Human cerebrospinal fluid at 20 µg
Secondary
All lanes:
VeriBlot for IP secondary antibody(HRP)(<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 27 kDa
Observed band size: 27 kDa
false
Related conjugates and formulations (1)
-
Anti-Kallikrein 6 antibody [EPR23352-128] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KLK6 participates in the degradation of extracellular matrix components. It functions within complex proteolytic cascades facilitating tissue remodeling and repair. Additionally KLK6 interacts with other kallikreins like kallikrein 3 showing intricate regulation within the kallikrein-related peptidase network. This interplay points toward its importance in modulating extracellular environment and cellular interactions.
Pathways
KLK6 engages in the neurogenic and inflammatory response pathways. It ties into MAPK signaling influencing processes such as cell proliferation and apoptosis. Through these pathways KLK6 associates with proteins like MMPs which modulate extracellular matrix dynamics. Its presence in these pathways positions KLK6 as a significant regulatory protein during cellular homeostasis and stress responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
European journal of oral sciences 131:e12923 PubMed36788303
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com